SSRI - Treatment and bleeding: What risks do we take?;Blutungsrisiko unter SSRI-Behandlung

Nervenarzt

Volumn 81, Issue 5, 2010, Pages 549-555

  Strubel, T ^a   Birkhofer, A ^a   Momer G ^b   Forstl H ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Depression; Hemorrhage; Non steroidal anti inflammatory drugs; Platelet aggregation inhibitors; Selective serotonin reuptake inhibitors

Indexed keywords

ACETYLSALICYLIC ACID; CITALOPRAM; CLOPIDOGREL; COUMARIN; FLUOXETINE; FLUVOXAMINE; NONSTEROID ANTIINFLAMMATORY AGENT; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TICLOPIDINE; TRICYCLIC ANTIDEPRESSANT AGENT;

BLEEDING; BLEEDING DISORDER; BRAIN HEMORRHAGE; DRUG POTENTIATION; DRUG SAFETY; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HIGH RISK PATIENT; HUMAN; INCIDENCE; PRESCRIPTION; REVIEW; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION;

GASTROINTESTINAL HEMORRHAGE; HUMANS; RISK ASSESSMENT; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS;

EID: 77953618680     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-009-2824-z     Document Type: Review

References (39)

1. Bak S, Tsiropoulos I, Kjaersgaard JO et al (2002) Selective serotonin reuptake inhibitors and the risk of stroke: a population-based case-control study. Stroke 33:1465-1473
2. Bottlender R, Dobmeier P, Möller HJ (1998) The effect of selective serotonin-reuptake inhibitors in blood coagulation. Fortschr Neurol Psychiatr 66:32-35
3. Dalton SO, Johansen C, Mellemkjaer L et al (2003) Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population- based cohort study. Arch Intern Med 163:59-64
4. de Abajo FJ, Rodríguez LA, Montero D (1999) Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study. BMJ 319:1106-1109
5. de Abajo FJ, Jick H, Derby L et al (2000) Intracranial haemorrhage and use of selective serotonin reuptake inhibitors. Br J Clin Pharmacol 50:43-47
6. de Abajo FJ, Montero D, Rodriguez LA et al (2006) Antidepressants and risk of upper gastrointestinal bleeding. Basic Clin Pharmacol Toxicol 98:304-310
7. de Jong JC, van den Berg PB, Tobi H et al (2003) Combined use of SSRIs and NSAIDs increases the risk of gastrointestinal adverse effects. Br J Clin Pharmacol 55:591-595
8. Dunn NR, Pearce GL, Shakir SA (2000) Association between SSRIs and upper gastrointestinal bleeding. SSRIs are no more likely than other drugs to cause such bleeding. BMJ 320:1405-1406
9. Halperin D, Reber G (2007) Influence of antidepressants on hemostasis. Dialogues Clin Neurosci 9:47-59
10. Hergovich N, Aigner M, Eichler HG et al (2000) Paroxetine decreases platelet serotonin storage and platelet function in human beings. Clin Pharmacol Ther 68:435-442
11. Hoeksema T, Goekoop JG, Van Kempen GM (1993) Effects of fluvoxamine on whole-blood serotonin and platelet number. J Clin Psychopharmacol 13:75-76
12. Kharofa J, Sekar P, Haverbusch M et al (2007) Selective serotonin reuptake inhibitors and risk of hemorrhagic stroke. Stroke 38:3049-3051
13. Kurdyak PA, Juurlink DN, Kopp A et al (2005) Antidepressants, warfarin and the risk of hemorrhage. J Clin Psychopharmacol 25:561-564
14. Layton D, Clark DW, Pearce GL et al (2001) Is there an association between selective serotonin reuptake inhibitors and risk of abnormal bleeding? Results from a cohort study based on prescription event monitoring in England. Eur J Clin Pharmacol 57:167-176
15. Li N, Wallén NH, Ladjevardi M et al (1997) Effects of serotonin on platelet activation in whole blood. Blood Coagul Fibrinolysis 8:517-523
16. Loke YK, Trivedi AN, Singh S (2008) Meta-analysis: gastrointestinal bleeding due to interaction between selective serotonin uptake inhibitors and non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 27:31-40
17. McCloskey DJ, Postolache TT, Vittone BJ et al (2008) Selective serotonin reuptake inhibitors: measurement of effect on platelet function. Transl Res 151:168-172
18. Meijer WE, Heerdink ER, Nolen WA et al (2004) Association of risk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepressants. Arch Intern Med 164:2367-2370
19. Mort JR, Aparasu RR, Baer RK (2006) Interaction between selective serotonin reuptake inhibitors and nonsteroidal antiinflammatory drugs: review of the literature. Pharmacotherapy 26:1307-1313
20. Movig KL, Janssen MW, de Waal Malefijt J et al (2003) Relationship of serotonergic antidepressants and need for blood transfusion in orthopedic surgical patients. Arch Intern Med 163:2354-2358
21. Opatrny L, Delaney JA, Suissa S (2008) Gastro-intestinal haemorrhage risks of selective serotonin receptor antagonist therapy: a new look. Br J Clin Pharmacol 60:76-81
22. Salkeld E, Ferris LE, Juurlink DN (2008) The risk of postpartum hemorrhage with selective serotonin reuptake inhibitors and other antidepressants. J Clin Psychopharmacol 28:230-234
23. Sauer WH, Berlin JA, Kimmel SE (2001) Selective serotonin reuptake inhibitors and myocardial infarction. Circulation 104:1894-1898
24. Sayal KS, Duncan-McConnell DA, McConnell HW et al (2000) Psychotropic interactions with warfarin. Acta Psychiatr Scand 102:250-255
25. Schalekamp T, Klungel OH, Souverein PC et al (2008) Increased bleeding risk with concurrent use of selective serotonin reuptake inhibitors and coumarins. Arch Intern Med 168:180-185
26. Schlienger RG, Fischer LM, Jick H et al (2004) Current use of selective serotonin reuptake inhibitors and risk of acute myocardial infarction. Drug Saf 27:1157-1165
27. Schwabe U, Paffrath D (Hrsg) (2006) Arzneiverordnungs- Report 2005 Aktuelle Daten, Kosten, Trends und Kommentare. Springer
28. Serebruany VL, Glassman AH, Malinin AI et al (2003) Sertraline AntiDepressant Heart Attack Randomized Trial Study Group. Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline Anti Depressant Heart Attack Randomized Trial (SADHART) Platelet Substudy. Circulation 108:939-944
29. Serebruany VL (2006) Selective serotonin reuptake inhibitors and increased bleeding risk: are we missing something? Am J Med 119:113-116
30. Takeuchi K, Tanaka A, Takahira Y et al (2005) Selective serotonin re-uptake inhibitors (SSRIs) aggravate antral ulcers induced by indomethacin in rat stomachs. Gastroenterology 128:A48, abstract 337
31. Tata LJ, Fortun PJ, Hubbard RB et al (2005) Does concurrent prescription of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding? Aliment Pharmacol Ther 22:175-181
32. Tatsumi M, Groshan K, Blakely RD et al (1997) Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol 340:249-258
33. Turner MS, May DB, Arthur RR et al (2007) Clinical impact of selective serotonin reuptake inhibitors therapy with bleeding risks. J Intern Med 261:205-213
34. Walraven C van, Mamdani MM, Wells PS et al (2001) Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study. BMJ 323:655-658
35. Vidal X, Ibáñez L, Vendrell L et al (2008) Risk of upper gastrointestinal bleeding and the degree of serotonin reuptake inhibition by antidepressants: a case-control study. Drug Saf 31:159-168
36. Visser LE, Penning-van Bees FJ, Kasbergen AA et al (2002) Overanticoagulation associated with combined use of antibacterial drugs and acenocoumarol or phenprocoumon anticoagulants. Thromb Haemost 88:705-710
37. Weinrieb RM, Auriacombe M, Lynch KG et al (2005) Selective serotonin re-uptake inhibitors and the risk of bleeding. Expert Opin Drug Saf 4:337-344
38. Wessinger S, Kaplan M, Choi L et al (2006) Increased use of selective serotonin reuptake inhibitors in patients admitted with gastrointestinal haemorrhage: a multicentre retrospective analysis. Aliment Pharmacol Ther 23:937-944
39. Yuan Y, Tsoi K, Hunt RH (2006) Selective serotonin reuptake inhibitors and risk of upper GI bleeding: confusion or confounding? Am J Med 119:719-727